EFSA Launches Full Re-evaluation of the Effects of Bisphenol A

25 Apr 2012 --- Experts on EFSA’s Panel on Food Contact Materials, Enzymes, Flavorings and Processing Aids (CEF) will further evaluate uncertainties about the possible relevance to human health of some BPA-related effects observed in rodents at low dose levels.

25 April 2012 --- The European Food Safety Authority (EFSA) has started work on its new risk assessment of bisphenol A (BPA), used in food contact materials, focusing in particular on exposure of vulnerable groups. The new opinion will complement earlier scientific advice provided at the request of the European Commission. EFSA will review all the available data and scientific studies on dietary exposure published since its 2006 opinion on BPA and also take into consideration the contribution of non-dietary sources to overall exposure to BPA.

Experts on EFSA’s Panel on Food Contact Materials, Enzymes, Flavorings and Processing Aids (CEF) will further evaluate uncertainties about the possible relevance to human health of some BPA-related effects observed in rodents at low dose levels. New findings from ongoing studies on low dose effects as well as on dietary and non-dietary exposure to BPA will be considered as they become available during 2012. EFSA is also convening a Colloquium of international experts to debate the most recent scientific evidence of low dose effects in toxicology and the challenges this poses for risk assessment.

At its February 2012 plenary meeting the CEF Panel proposed a co-ordinated work plan for the full re-evaluation of the human risks associated with exposure to BPA through the diet by May 2013. This initiative was taken in light of EFSA’s ongoing monitoring of scientific research on BPA and the CEF Panel’s further consideration of new scientific studies. Two multidisciplinary working groups of experts have been established to focus, respectively, on the hazard characterization of BPA (concerning its toxicological effects) and on exposure to BPA (how and how much BPA is absorbed by the human body). To enhance EU-wide cooperation, experts from national authorities undertaking related scientific work on BPA have also been invited to contribute to the working groups.

In recent years, efforts have been made to reduce exposure to BPA, particularly for vulnerable population groups such as infants, children and pregnant women, and baby bottles made of BPA-containing polycarbonate plastics have been banned. EFSA will launch a call for data from Member States to provide an up-to-date indication of the occurrence of BPA in food as well as the amount of BPA residue that migrates from food contact materials into food.

In carrying out this comprehensive risk assessment EFSA will also liaise with scientific experts in the Member States and in the United States on risk assessment reports in preparation and on large scale studies currently in progress. Further, EFSA will specifically tackle the issue of low dose effects in toxicology and risk assessment at its dedicated Scientific Colloquium, taking place in Parma on 14-15 June; several leading scientists from Europe and North America have already confirmed their attendance. Registration for the Colloquium is open until 30 April 2012 or until seating capacity is filled.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Dosage questions: Green tea supplements may pose health risks, EFSA warns

19 Apr 2018 --- When taken as food supplements, green tea catechin doses at or above 800mg/day may pose health concerns, according to the European Food Safety Authority (EFSA), which assessed the safety of green tea catechins from dietary sources, following concerns regarding their possible harmful effects on the liver. Catechins from green tea infusions and similar drinks are generally safe, the authority found, but certain supplements may be best avoided.

Nutrition & Health News

Phospholipid formulation reduces PMS stress, trial finds

27 Mar 2018 --- A natural phospholipid formulation – Lipogen PMS – has been shown to relieve premenstrual syndrome (PMS) symptoms. The product "fills a huge void in the market" as one of the few, non-pharmaceutical solutions for PMS symptom relief, claims the company. PMS refers to physical and emotional symptoms that occur one to two weeks before a woman’s period. PMS is experienced by 20 to 30 percent of women, according to the American Family Physician Journal, and Lipogen can offer "potential relief with a progressive, natural solution without unwanted secondary effects."

Regulatory News

Health claim victory: EFSA confirms physical performance benefits of carbohydrate solutions

14 Mar 2018 --- The European Food Safety Authority (EFSA) has published a scientific assessment confirming the beneficial health effects of glycemic carbohydrates on the improvement of physical performance during high-intensity and long-lasting physical exercise. As a result, sports nutrition companies will be able to include on-pack claims regarding the performance boosting capacity of products containing carbohydrate solutions (CHO). 

Nutrition & Health News

Cholesterol lowering: Staying low to ward off heart health troubles

28 Feb 2018 --- Cholesterol’s deadly relationship with heart disease is well known around the world today. Cardiovascular disease continues to be one of the world’s most urgent health problems – for example, heart failure affects about 6.5 million adults over age 20 in the US, according to the American Heart Association.

Nutrition & Health News

Botanically speaking: Indena highlights the link between health and plants species 

27 Feb 2018 --- Indena is leading innovation, development and production of active principles derived from plants, for use in the pharmaceutical and health-food industries. Recently, the company announced that the French Ministry of Higher Education, Research and Innovation has renewed to the company the recognition to act as an organization carrying out R&D activities for the account of private companies. Indena received this recognition for the first time in 2011. Since then, it has always been renewed, but this time for a particularly significant period: five years, up to 2022.

More Articles
URL : http://www.nutritioninsight.com:80/news/EFSA-Launches-Full-Re-evaluation-of-the-Effects-of-Bisphenol-A.html